PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.\', \'Department of Biochemistry, Microbiology, and Immunology, University of Ottawa, Ottawa, ON, Canada.\', \'Division of General Surgery, Department of Surgery, University of Ottawa, Ottawa, ON, Canada.\', \'Schulich School of Medicine, University of Western Ontario, London, ON, Canada.\', \'Centre for Infection, Immunity, and Inflammation, University of Ottawa, Ottawa, ON, Canada.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.3389/fimmu.2020.01512
?:doi
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 32655581
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
is ?:relation_isRelatedTo_publication of
?:title
  • Flattening the COVID-19 Curve With Natural Killer Cell Based Immunotherapies.
?:type

Metadata

Anon_0  
expand all